Pravin Shankar Giri

Employment

• Indian Institute of Technology Hyderabad Ph.D Scholar
  2018 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (10)

• Copper-Substituted Calcium-Deficient Apatite: Enhancing Osteogenic and Angiogenic Synergy for Bioengineered Bone Regeneration
  ACS Biomaterials Science & Engineering 2025 DOI: 10.1021/acsbiomaterials.5c00894
  +Save
• Flavin-based probe for real-time monitoring of hypochlorous acid dynamics in live cells
  Journal of Materials Chemistry B 2025 DOI: 10.1039/D4TB02727B
  +Save
• Macrophage Polarization Dynamics in Biomaterials: Implications for in Vitro Wound Healing
  ACS Applied Bio Materials 2024 DOI: 10.1021/acsabm.4c00066
  +Save
• A Neutral Flavin–Triphenylamine Probe for Mitochondrial Bioimaging under Different Microenvironments
  ACS Medicinal Chemistry Letters 2023 DOI: 10.1021/acsmedchemlett.3c00446
  +Save
• 3D Bioprintable Hypoxia-Mimicking PEG-Based Nano Bioink for Cartilage Tissue Engineering
  ACS Applied Materials & Interfaces 2023 DOI: 10.1021/acsami.3c00389
  +Save
• Osteomatrix as a personalized 3D tissue-specific invasion test-bed for oral carcinoma
  Biomaterials Science 2023 DOI: 10.1039/d2bm01870e
  +Save
• Bioengineering strategies for 3D bioprinting of tubular construct using tissue-specific decellularized extracellular matrix
  International Journal of Biological Macromolecules 2022 DOI: 10.1016/j.ijbiomac.2022.11.064
  +Save
• Biocompatibility-on-a-chip: Characterization and evaluation of decellularized tendon extracellular matrix (tdECM) hydrogel for 3D stem cell culture in a microfluidic device
  International Journal of Biological Macromolecules 2022 DOI: 10.1016/j.ijbiomac.2022.06.010
  +Save
• Modulation of 3D Printed Calcium-Deficient Apatite Constructs with Varying Mn Concentrations for Osteochondral Regeneration via Endochondral Differentiation
  ACS Applied Materials & Interfaces 2022 DOI: 10.1021/acsami.2c05110
  +Save
• Adjuvant role of a T-type calcium channel blocker, TTA-A2, in lung cancer treatment with paclitaxel
  Cancer Drug Resistance 2021 DOI: 10.20517/cdr.2021.54
  +Save